• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

活体和离体光学成像检测骨髓基质细胞脑内移植对脑缺血后组织型纤溶酶原激活物诱导的脑损伤的改善作用

Intracerebral transplantation of bone marrow stromal cells ameliorates tissue plasminogen activator-induced brain damage after cerebral ischemia in mice detected by in vivo and ex vivo optical imaging.

机构信息

Department of Neurology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.

出版信息

J Neurosci Res. 2012 Nov;90(11):2086-93. doi: 10.1002/jnr.23104. Epub 2012 Jul 13.

DOI:10.1002/jnr.23104
PMID:22791305
Abstract

Detection and protection of the neurovascular unit (NVU) are essential for treatment of acute stroke patients, especially the use of tissue plasminogen activator (tPA). In the present study, we conducted in vivo and ex vivo optical imaging for detecting activation of matrix metalloproteinases (MMPs) and evaluated the protective effect of intracerebral transplantation of bone marrow stromal cells (BMSCs) obtained from green fluorescent protein (GFP) transgenic (Tg) mice on the NVU in tPA-mediated brain damage after transient middle cerebral artery occlusion (tMCAO) in mice. Compared with the tMCAO group, the tMCAO plus BMSC group showed significant reductions of in vivo and ex vivo fluorescent signals for MMPs at 48 hr after tMCAO, with a partial colocalization of BMSC-GFP signals. Intracerebrally transplanted BMSCs ameliorated MMP-9 activation by immunohistochemistry and Western blot with differentiation into microglial and astroglial cells. Double-immunofluorescence study revealed improved NVU disruption in the tMCAO plus BMSC group. The present study suggests that intracerebral BMSC transplantation reduced MMP activation and subsequent NVU disruption caused by tPA after tMCAO and that this MMP activation and BMSC effect were detectable with in vivo and ex vivo optical imaging.

摘要

检测和保护神经血管单元(NVU)对于急性中风患者的治疗至关重要,特别是组织型纤溶酶原激活剂(tPA)的应用。在本研究中,我们进行了体内和离体光学成像,以检测基质金属蛋白酶(MMPs)的激活,并评估来自绿色荧光蛋白(GFP)转基因(Tg)小鼠的脑基质细胞(BMSC)颅内移植对 tPA 介导的短暂性大脑中动脉闭塞(tMCAO)后 NVU 的保护作用在小鼠。与 tMCAO 组相比,tMCAO 加 BMSC 组在 tMCAO 后 48 小时显示 MMPs 的体内和离体荧光信号显著减少,BMSC-GFP 信号部分共定位。脑内移植的 BMSCs 通过免疫组织化学和 Western blot 改善 MMP-9 的激活,并分化为小胶质细胞和星形胶质细胞。双免疫荧光研究显示 tMCAO 加 BMSC 组中 NVU 破坏得到改善。本研究表明,脑内 BMSC 移植可减少 tMCAO 后 tPA 引起的 MMP 激活和随后的 NVU 破坏,并且这种 MMP 激活和 BMSC 作用可以通过体内和离体光学成像检测到。

相似文献

1
Intracerebral transplantation of bone marrow stromal cells ameliorates tissue plasminogen activator-induced brain damage after cerebral ischemia in mice detected by in vivo and ex vivo optical imaging.活体和离体光学成像检测骨髓基质细胞脑内移植对脑缺血后组织型纤溶酶原激活物诱导的脑损伤的改善作用
J Neurosci Res. 2012 Nov;90(11):2086-93. doi: 10.1002/jnr.23104. Epub 2012 Jul 13.
2
In vivo optical imaging correlates with improvement of cerebral ischemia treated by intravenous bone marrow stromal cells (BMSCs) and edaravone.体内光学成像与静脉注射骨髓基质细胞(BMSCs)和依达拉奉治疗脑缺血的改善情况相关。
Neurol Res. 2013 Dec;35(10):1051-8. doi: 10.1179/1743132813Y.0000000252. Epub 2013 Aug 16.
3
In vivo optical imaging for evaluating the efficacy of edaravone after transient cerebral ischemia in mice.在体光学成像评估依达拉奉治疗小鼠短暂性脑缺血的疗效。
Brain Res. 2011 Jun 23;1397:66-75. doi: 10.1016/j.brainres.2011.04.038. Epub 2011 Apr 27.
4
Strong neuroprotection with a novel platinum nanoparticle against ischemic stroke- and tissue plasminogen activator-related brain damages in mice.新型铂纳米颗粒对缺血性脑卒中及组织型纤溶酶原激活物相关脑损伤的神经保护作用。
Neuroscience. 2012 Sep 27;221:47-55. doi: 10.1016/j.neuroscience.2012.06.060. Epub 2012 Jul 3.
5
A broad-spectrum matrix metalloproteinase inhibitor prevents hemorrhagic complications induced by tissue plasminogen activator in mice.一种广谱基质金属蛋白酶抑制剂可预防组织型纤溶酶原激活物诱导的小鼠出血并发症。
Neuroscience. 2012 Mar 15;205:39-48. doi: 10.1016/j.neuroscience.2011.12.042. Epub 2012 Jan 5.
6
Transfection of Noggin in bone marrow stromal cells (BMSCs) enhances BMSC-induced functional outcome after stroke in rats.转染 Noggin 基因可增强骨髓基质细胞(BMSCs)诱导的大鼠脑卒中风后功能恢复。
J Neurosci Res. 2011 Aug;89(8):1194-202. doi: 10.1002/jnr.22662. Epub 2011 May 4.
7
Recombinant tissue plasminogen activator induces blood-brain barrier breakdown by a matrix metalloproteinase-9-independent pathway after transient focal cerebral ischemia in mouse.重组组织型纤溶酶原激活剂在短暂性局灶性脑缺血后通过基质金属蛋白酶-9 非依赖性途径诱导血脑屏障破裂。
Eur J Neurosci. 2011 Oct;34(7):1085-92. doi: 10.1111/j.1460-9568.2011.07843.x. Epub 2011 Sep 6.
8
In vivo tracking of bone marrow stromal cells transplanted into mice cerebral infarct by fluorescence optical imaging.通过荧光光学成像对移植到小鼠脑梗死区域的骨髓基质细胞进行体内追踪。
Brain Res Brain Res Protoc. 2004 Aug;13(3):166-75. doi: 10.1016/j.brainresprot.2004.04.004.
9
Microglial-mediated PDGF-CC activation increases cerebrovascular permeability during ischemic stroke.小胶质细胞介导的血小板衍生生长因子-CC 激活增加缺血性脑卒中期间的脑血管通透性。
Acta Neuropathol. 2017 Oct;134(4):585-604. doi: 10.1007/s00401-017-1749-z. Epub 2017 Jul 19.
10
Lipoprotein receptor-mediated induction of matrix metalloproteinase by tissue plasminogen activator.脂蛋白受体介导的组织纤溶酶原激活物对基质金属蛋白酶的诱导作用。
Nat Med. 2003 Oct;9(10):1313-7. doi: 10.1038/nm926. Epub 2003 Sep 7.

引用本文的文献

1
Protection against brain injury after ischemic stroke by intravenous human amnion epithelial cells in combination with tissue plasminogen activator.静脉注射人羊膜上皮细胞联合组织型纤溶酶原激活剂对缺血性中风后脑损伤的保护作用。
Front Neurosci. 2023 Jun 16;17:1157236. doi: 10.3389/fnins.2023.1157236. eCollection 2023.
2
The Effects and Underlying Mechanisms of Cell Therapy on Blood-Brain Barrier Integrity After Ischemic Stroke.细胞治疗对缺血性脑卒中后血脑屏障完整性的影响及其作用机制。
Curr Neuropharmacol. 2020;18(12):1213-1226. doi: 10.2174/1570159X18666200914162013.
3
Combination therapy for ischemic stroke: Novel approaches to lengthen therapeutic window of tissue plasminogen activator.
缺血性中风的联合治疗:延长组织纤溶酶原激活剂治疗窗的新方法。
Brain Circ. 2018 Jul-Sep;4(3):99-108. doi: 10.4103/bc.bc_21_18. Epub 2018 Oct 9.
4
Adjunctive Therapy Approaches for Ischemic Stroke: Innovations to Expand Time Window of Treatment.缺血性脑卒中的辅助治疗方法:扩大治疗时间窗的创新。
Int J Mol Sci. 2017 Dec 19;18(12):2756. doi: 10.3390/ijms18122756.
5
Bone marrow mesenchymal stem cell therapy in ischemic stroke: mechanisms of action and treatment optimization strategies.骨髓间充质干细胞治疗缺血性脑卒中:作用机制与治疗优化策略
Neural Regen Res. 2016 Jun;11(6):1015-24. doi: 10.4103/1673-5374.184506.
6
Pre- and postmortem imaging of transplanted cells.移植细胞的生前和死后成像。
Int J Nanomedicine. 2015 Sep 2;10:5543-59. doi: 10.2147/IJN.S83557. eCollection 2015.
7
Neurorestorative therapy for stroke.脑卒中的神经修复治疗。
Front Hum Neurosci. 2014 Jun 27;8:382. doi: 10.3389/fnhum.2014.00382. eCollection 2014.
8
Bone marrow stromal cells as a therapeutic treatment for ischemic stroke.骨髓基质细胞作为一种治疗缺血性中风的方法。
Neurosci Bull. 2014 Jun;30(3):524-34. doi: 10.1007/s12264-013-1431-y. Epub 2014 May 10.
9
Cell based therapies for ischemic stroke: from basic science to bedside.缺血性中风的细胞疗法:从基础科学到临床应用
Prog Neurobiol. 2014 Apr;115:92-115. doi: 10.1016/j.pneurobio.2013.11.007. Epub 2013 Dec 12.
10
Update on therapeutic mechanism for bone marrow stromal cells in ischemic stroke.骨髓基质细胞在缺血性卒中治疗机制的研究进展
J Mol Neurosci. 2014 Feb;52(2):177-85. doi: 10.1007/s12031-013-0119-0. Epub 2013 Sep 19.